MAB-CHMINACA

1863065-92-2

CAS-Nr.: 1863065-92-2

Englisch Name:: MAB-CHMINACA

Synonyma:: MAB-CHMINACA;MAB-CHMINACA (CRM);MAB-CHMINACA SOLUTION;ZWCCSIUBHCZKOY-UHFFFAOYSA-N;N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide;N-[1-(Aminocarbonyl)-2,2-dimethylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide;1H-Indazole-3-carboxamide, N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-(cyclohexylmethyl)-

CBNumber:: CB72747366

Summenformel:: C21H30N4O2

Molgewicht:: 370.49

MOL-Datei:: 1863065-92-2.mol

Eigenschaften Sicherheit Verwendungswort

MAB-CHMINACA Eigenschaften

storage temp.: -20°C

Löslichkeit: DMF: 5 mg/ml; DMSO: 10 mg/ml; DMSO:PBS(pH7.2) (1:1): 0.5 mg/ml; Ethanol: 1 mg/ml

Aggregatzustand: A neat solid

Sicherheit

RIDADR	UN1230 - class 3 - PG 2 - Methanol, solution
DEA Controlled Substances	CSCN: 7032 CSA SCH: Schedule I NARC: No

MAB-CHMINACA Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

AB-CHMINACA is an indazole-based synthetic cannabinoid (CB) that is structurally related to AB-FUBINACA (Item Nos. ISO60211 | ISO00134 | 14039), a high affinity ligand of the CB₁ receptor (K_i = 0.9 nM). MAB-CHMINACA is structurally similar to AB-CHMINACA by bearing an identical cyclohexyl group; however, the isobutyl moiety is substituted with a tert-butyl group. It is a potent agonist of the CB₁ receptor with a reported K_i value of 0.289 nM. This product is intended for forensic and research applications.

MAB-CHMINACA Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

MAB-CHMINACA
MAB-CHMINACA SOLUTION
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide
ZWCCSIUBHCZKOY-UHFFFAOYSA-N
MAB-CHMINACA (CRM)
1H-Indazole-3-carboxamide, N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-(cyclohexylmethyl)-
N-[1-(Aminocarbonyl)-2,2-dimethylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide
1863065-92-2
pharmaceutical intermediates